Ngā hua rapu - Jason A Roberts

Whakamahine hua
  1. 1
    Antibacterial Dosing in Intensive Care

    Antibacterial Dosing in Intensive Care mā Jason A. Roberts, Jeffrey Lipman

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock

    Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock mā Julie Varghese, Jason A. Roberts, Jeffrey Lipman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Clinical implications of antibiotic pharmacokinetic principles in the critically ill

    Clinical implications of antibiotic pharmacokinetic principles in the critically ill mā Andrew Udy, Jason A. Roberts, Jeffrey Lipman

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The Clinical Relevance of Plasma Protein Binding Changes

    The Clinical Relevance of Plasma Protein Binding Changes mā Jason A. Roberts, Federico Pea, Jeffrey Lipman

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones

    Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones mā Claire Roger, Jason A. Roberts, Laurent Müller

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Optimization of dosing regimens and dosing in special populations

    Optimization of dosing regimens and dosing in special populations mā Fekade B. Sime, Michael S. Roberts, Jason A. Roberts

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Elevating the Quality of Disability and Rehabilitation Research: Mandatory Use of the Reporting Guidelines

    Elevating the Quality of Disability and Rehabilitation Research: Mandatory Use of the Reporting Guidelines mā Leighton Chan, Allen W. Heinemann, Jason A. Roberts

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy

    Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy mā Jason A. Roberts, Katherine F Croom, Nicholas Adomakoh

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    β‐<scp>L</scp>actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review

    β‐<scp>L</scp>actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review mā Mahipal Sinnollareddy, Michael S. Roberts, Jeffrey Lipman, Jason A. Roberts

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?

    Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? mā Jason A. Roberts, Jeffrey Lipman, Stijn Blot, Jordi Rello

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients

    Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients mā Jason A. Roberts, Carl M. J. Kirkpatrick, Jeffrey Lipman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics

    The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics mā Andrew Udy, Jason A. Roberts, Jeffrey Lipman, Stijn Blot

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Therapeutic drug monitoring of antimicrobials

    Therapeutic drug monitoring of antimicrobials mā Jason A. Roberts, Ross Norris, David L. Paterson, Jennifer Martin

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Risk Factors in Hospitalized Patients With Burn Injuries for Developing Heterotopic Ossification—A Retrospective Analysis

    Risk Factors in Hospitalized Patients With Burn Injuries for Developing Heterotopic Ossification—A Retrospective Analysis mā Gregory R. Orchard, Jennifer Paratz, Stijn Blot, Jason A. Roberts

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

    How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? mā Gloria Wong, Fekade B. Sime, Jeffrey Lipman, Jason A. Roberts

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?

    The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? mā Stijn Blot, Jeffrey Lipman, Darren M. Roberts, Jason A. Roberts

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review

    The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review mā Sonali Coulter, Katharina Merollini, Jason A. Roberts, Nicholas Graves, Kate Halton

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?: Figure 1.

    Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?: Figure 1. mā Angela Huttner, Stephan Harbarth, William Hope, Jeffrey Lipman, Jason A. Roberts

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Optimising drug dosing in patients receiving extracorporeal membrane oxygenation

    Optimising drug dosing in patients receiving extracorporeal membrane oxygenation mā Vesa Cheng, Mohd H. Abdul‐Aziz, Jason A. Roberts, Kiran Shekar

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Augmented Renal Clearance

    Augmented Renal Clearance mā Andrew Udy, Jason A. Roberts, Robert Boots, David L. Paterson, Jeffrey Lipman

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: